Filing Details

Accession Number:
0000711377-14-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-30 10:43:30
Reporting Period:
2014-07-29
Filing Date:
2014-07-30
Accepted Time:
2014-07-30 10:43:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Ceo & Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-07-29 10,000 $18.68 900,113 No 4 M Direct
Common Stock Disposition 2014-07-29 10,000 $44.17 890,113 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2014-07-29 10,000 $0.00 10,000 $18.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
348,250 2015-08-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 378,480 Indirect See Footnote
Footnotes
  1. Options were granted 8/24/2010, have five year lives, vest in equal annual installments beginning on the anniversary date of the grant, and expire on 8/24/2015
  2. 180,000 are held in a limited partnership, of which Mr. Herbert is the sole owner, and 198,480 shares are held in trust for Mr. Herbert's spouse